ABVC logo

ABVC BioPharma (ABVC) Revenue

Annual Revenue

$152.40 K
-$817.40 K-84.29%

December 31, 2023

Summary

Performance

1-Year Change

-84.29%

3-Year Change

-68.45%

5-Year Change

-

15-Year Change

-

ABVC Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.76%
ABVC annual revenue is higher than 5.76% of companies in Healthcare sector

High & Low

All-time High

$969.80 K
ABVC annual revenue is currently -84.29% below its historical high of $969.80 thousand

3-Year Low

$152.40 K
ABVC annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABVC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
ABVC next annual earnings announcement is scheduled for Mar 14, 2025

OtherABVCprofitabilitymetrics:

Annual EPS

-$2.43
ABVC annual earnings per share is -$2.43

Annual Net Income

-$10.52 M
ABVC annual net profit is -$10.52 million

Annual Operating Profit

-$8.22 M
ABVC annual operating income is -$8.22 million

Annual Gross Profit

-$149.60 K
ABVC annual gross profit is -$149.60 thousand

Quarterly Revenue

$389.30 K
+$272.20 K+232.45%

September 30, 2024

Summary

Performance

3-Month Change

+232.45%

1-Year Change

+2348.43%

3-Year Change

+293.23%

5-Year Change

+293.23%

ABVC Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.38%
ABVC quarterly revenue is higher than 13.38% of companies in Healthcare sector

High & Low

All-time High

$589.00 K
ABVC quarterly revenue is currently -33.90% below its historical high of $589.00 thousand

3-Year Low

-$37.80 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABVC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ABVC next earnings announcement is scheduled for Mar 14, 2025

Related metrics

Quarterly Gross Profit

$389.00 K
ABVC quarterly gross profit is $389.00 thousand

Quarterly Operating Profit

$49.90 K
ABVC quarterly operating income is $49.90 thousand

Quarterly Net Income

-$186.60 K
ABVC quarterly net profit is -$186.60 thousand

Quarterly EPS

-$0.02
ABVC quarterly earnings per share is -$0.02

TTM Revenue

$509.80 K
+$373.40 K+273.75%

September 30, 2024

Summary

Performance

3-Month Change

+273.75%

1-Year Change

-31.04%

3-Year Change

+11.87%

5-Year Change

+11.87%

ABVC TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.25%
ABVC TTM revenue is higher than 8.25% of companies in Healthcare sector

High & Low

All-time High

$1.07 M
ABVC TTM revenue is currently -52.47% below its historical high of $1.07 million

3-Year Low

$25.40 K
ABVC TTM revenue is currently +1907.09% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABVC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ABVC next earnings announcement is scheduled for Mar 14, 2025

OtherABVCprofitabilitymetrics:

TTM Gross Profit

$369.90 K
ABVC TTM gross profit is $369.90 thousand

TTM Operating Profit

-$6.33 M
ABVC TTM operating income is -$6.33 million

TTM Net Income

-$8.24 M
ABVC TTM net profit is -$8.24 million

TTM EPS

-$0.90
ABVC TTM earnings per share is -$0.90

ABVC Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-84.3%+2348.4%-31.0%
3 y3 years-68.5%+293.2%+11.9%
5 y5 years-+293.2%+11.9%

ABVC Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-84.3%at low-33.9%+1129.9%-52.5%+1907.1%
5 y5-year-84.3%at low-33.9%+1129.9%-52.5%+1907.1%
alltimeall time-84.3%+4662.5%-33.9%+1129.9%-52.5%>+9999.0%

ABVC BioPharma Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$389.30 K(+232.5%)
$509.80 K(+273.8%)
Jun 2024
-
$117.10 K(+9658.3%)
$136.40 K(+437.0%)
Mar 2024
-
$1200.00(-45.5%)
$25.40 K(-83.3%)
Dec 2023
$152.40 K(-84.3%)
$2200.00(-86.2%)
$152.50 K(-79.4%)
Sep 2023
-
$15.90 K(+160.7%)
$739.30 K(-3.4%)
Jun 2023
-
$6100.00(-95.2%)
$765.70 K(-28.6%)
Mar 2023
-
$128.30 K(-78.2%)
$1.07 M(+10.6%)
Dec 2022
$969.80 K(+172.6%)
$589.00 K(+1292.4%)
$969.90 K(+182.7%)
Sep 2022
-
$42.30 K(-86.5%)
$343.10 K(-14.2%)
Jun 2022
-
$312.90 K(+1117.5%)
$399.80 K(+238.0%)
Mar 2022
-
$25.70 K(-168.0%)
$118.30 K(-66.7%)
Dec 2021
$355.80 K(-26.3%)
-$37.80 K(-138.2%)
$355.70 K(-21.9%)
Sep 2021
-
$99.00 K(+215.3%)
$455.70 K(-3.5%)
Jun 2021
-
$31.40 K(-88.1%)
$472.30 K(-29.2%)
Mar 2021
-
$263.10 K(+323.0%)
$667.40 K(+38.1%)
Dec 2020
$483.00 K(-31.2%)
$62.20 K(-46.2%)
$483.10 K(-7.3%)
Sep 2020
-
$115.60 K(-49.0%)
$520.90 K(-13.6%)
Jun 2020
-
$226.50 K(+187.4%)
$603.00 K(+6.1%)
Mar 2020
-
$78.80 K(-21.2%)
$568.30 K(-19.0%)
Dec 2019
$701.70 K(>+9900.0%)
$100.00 K(-49.4%)
$701.70 K(+17.4%)
Sep 2019
-
$197.70 K(+3.1%)
$597.70 K(+49.2%)
Jun 2019
-
$191.80 K(-9.6%)
$400.70 K(+88.9%)
Mar 2019
-
$212.20 K(-5405.0%)
$212.10 K(<-9900.0%)
Dec 2018
-
-$4000.00(-671.4%)
-$100.00(-102.6%)
Sep 2018
-
$700.00(-78.1%)
$3900.00(+21.9%)
Jun 2018
-
$3200.00(+190.9%)
$3200.00(-5.9%)
DateAnnualQuarterlyTTM
Sep 2015
$3400.00(-56.4%)
$1100.00(-52.2%)
$3400.00(+47.8%)
Mar 2015
-
$2300.00(+187.5%)
$2300.00(-70.5%)
Sep 2013
$7800.00(+36.8%)
-
-
Mar 2013
-
$800.00(-88.6%)
$7800.00(-27.1%)
Dec 2012
-
$7000.00(+89.2%)
$10.70 K(+87.7%)
Sep 2012
$5700.00(+78.1%)
-
-
Mar 2012
-
$3700.00(+85.0%)
$5700.00(+111.1%)
Dec 2011
-
$2000.00(+185.7%)
$2700.00(-62.0%)
Sep 2011
$3200.00(-78.5%)
-
-
Mar 2011
-
$700.00(-72.0%)
$7100.00(-39.8%)
Dec 2010
-
$2500.00(+127.3%)
$11.80 K(-20.3%)
Sep 2010
$14.90 K(-40.6%)
$1100.00(-60.7%)
$14.80 K(+8.0%)
Jun 2010
-
$2800.00(-48.1%)
$13.70 K(+25.7%)
Mar 2010
-
$5400.00(-1.8%)
$10.90 K(-33.5%)
Dec 2009
-
$5500.00(-49.5%)
$16.40 K(+8.6%)
Mar 2009
-
$10.90 K(+5350.0%)
$15.10 K(-39.6%)
Sep 2008
$25.10 K(-39.8%)
$200.00(-95.0%)
$25.00 K(+0.8%)
Jun 2008
-
$4000.00(-61.5%)
$24.80 K(-20.5%)
Mar 2008
-
$10.40 K(0.0%)
$31.20 K(+50.0%)
Dec 2007
-
$10.40 K(0.0%)
$20.80 K(0.0%)
Sep 2007
$41.70 K(+204.4%)
-
-
Jun 2007
-
$10.40 K(0.0%)
$20.80 K(+100.0%)
Sep 2006
-
$10.40 K(-81.0%)
$10.40 K(-81.3%)
Sep 2004
-
$54.80 K(+6750.0%)
$55.60 K(+6850.0%)
Mar 2004
-
$800.00
$800.00
Dec 2003
$13.70 K
-
-

FAQ

  • What is ABVC BioPharma annual revenue?
  • What is the all time high annual revenue for ABVC BioPharma?
  • What is ABVC BioPharma annual revenue year-on-year change?
  • What is ABVC BioPharma quarterly revenue?
  • What is the all time high quarterly revenue for ABVC BioPharma?
  • What is ABVC BioPharma quarterly revenue year-on-year change?
  • What is ABVC BioPharma TTM revenue?
  • What is the all time high TTM revenue for ABVC BioPharma?
  • What is ABVC BioPharma TTM revenue year-on-year change?

What is ABVC BioPharma annual revenue?

The current annual revenue of ABVC is $152.40 K

What is the all time high annual revenue for ABVC BioPharma?

ABVC BioPharma all-time high annual revenue is $969.80 K

What is ABVC BioPharma annual revenue year-on-year change?

Over the past year, ABVC annual revenue has changed by -$817.40 K (-84.29%)

What is ABVC BioPharma quarterly revenue?

The current quarterly revenue of ABVC is $389.30 K

What is the all time high quarterly revenue for ABVC BioPharma?

ABVC BioPharma all-time high quarterly revenue is $589.00 K

What is ABVC BioPharma quarterly revenue year-on-year change?

Over the past year, ABVC quarterly revenue has changed by +$373.40 K (+2348.43%)

What is ABVC BioPharma TTM revenue?

The current TTM revenue of ABVC is $509.80 K

What is the all time high TTM revenue for ABVC BioPharma?

ABVC BioPharma all-time high TTM revenue is $1.07 M

What is ABVC BioPharma TTM revenue year-on-year change?

Over the past year, ABVC TTM revenue has changed by -$229.50 K (-31.04%)